Antifungal activity of itraconazole and voriconazole against clinical isolates obtained from animals with mycoses

Japanese Journal of Medical Mycology

Volumn 50, Issue 2, 2009, Pages 91-94

  Okabayashi, Ken ^a   Imaji, Mashio ^a   Osumi, Takafumi ^a   Murakami, Yoshihiko ^a   Maruyama, Haruhiko ^a   Kano, Rui ^a   Hasegawa, Atsuhiko ^a   Watanabe, Toshi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Aspergillus fumigatus; Candida spp.; Cryptococcus neoformans; Itraconazole; Voriconazole

Indexed keywords

ITRACONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA; CRYPTOCOCCUS NEOFORMANS; DRUG SENSITIVITY; FUNGAL STRAIN; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN;

ANIMALS; ANTIFUNGAL AGENTS; CAT DISEASES; CATS; DOG DISEASES; DOGS; ITRACONAZOLE; MYCOSES; PYRIMIDINES; TRIAZOLES;

ANIMALIA; ASPERGILLUS; ASPERGILLUS FUMIGATUS; CANDIDA; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 66249104706     PISSN: 09164804     EISSN: None     Source Type: Journal    
DOI: 10.3314/jjmm.50.091     Document Type: Article

References (19)

1. Davies C, Troy GC: Deep mycotic infections in cats. J Am Anim Hosp Assoc 32: 380-391, 1996. (Pubitemid 26305142)
2. Hironaga M, Ikeda R, Fukazawa Y, Watanabe S: Mating types and serotypes of Cryptococcus neoformans isolated in Japan. Sabouraudia 21: 73-78, 1983.
3. Okabayashi K, Kano R, Watanabe T, Hasegawa A: Serotypes and mating types of clinical isolates from feline cryptococcosis in Japan. J Vet Med Sci 68: 91-94, 2006. (Pubitemid 43208161)
4. Kano R, Hattori Y, Okuzumi K, Miyazaki Y, Yamauchi R, Koie H, Watari T, Hasegawa A: Detection and identification of the Candida species by 25S ribosomal DNA analysis in the urine of candidal cystitis. J Vet Med Sci 64: 115-117, 2002.
5. Pressler BM, Vaden SL, Lane IF, Cowgill LD, Dye JA: Candida spp. urinary tract infections in 13 dogs and seven cats: predisposing factors, treatment, and outcome. J Am Anim Hosp Assoc 39: 263-270, 2003.
6. Silvanose CD, Bailey TA, Di Somma A: Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole. Vet Rec 159: 282-284, 2006.
7. Tell LA: Aspergillosis in mammals and birds: impact on veterinary medicine. Med Mycol 43: S71-S73, 2005.
8. Hector RF: An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals. Clin Tech Small Anim Pract 20: 240-249, 2005. (Pubitemid 41543120)
9. George D, Miniter P, Andriole VT: Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis. Antimicrob Agents Chemother 40: 86-91, 1996. (Pubitemid 26020748)
10. Pal M, Onda C, Hasegawa A: Isolation of saprophytic Cryptococcus neoformans. Jpn J Vet Sci 52: 1171-1174, 1990.
11. Takashio, M: Sexual reproduction of some Arthroderma and Nanizzia on diluted Sabouraud agar with or without salts. Mykosen, 15: 11-17, 1972.
12. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard-Second edition M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA. 22(15): 2002.
13. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, PA. 22(16): 2002.
14. Pfaller, MA, Diekema DJ, Rex JH, Espinel-Ingroff A, Johnson EM, Andes D, Chaturvedi V, Ghannoum MA, Odds FC, Rinaldi MG, Sheehan DJ, Troke P, Walsh TJ, Warnock DW : Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin. Microbiol 44: 819-826, 2006.
15. Pfaller MA, Zhang J, Messer SA, Brandt ME, Hajjeh RA, Jessup CJ, Tumberland M, Mbidde EK, Ghannoum MA: In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother 43: 169-171, 1999.
16. Souza LK, Fernandes Ode F, Kobayashi CC, Passos XS, Costa CR, Lemos JA, Souza-Júnior AH, Silva Mdo R: Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiania city, Goias, Brazil. Rev Inst Med Trop Sao Paulo 47: 253-256, 2005.
17. Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S: National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother 53: 283-289, 2004.
18. Maesaki S, Iwakawa J, Higashiyama Y, Miyazaki Y, Yanagihara K, Tomono K, Tashiro T, Kohno S: Antifungal activity of a new triazole, voriconazole (UK-109496), against clinical isolates of Aspergillus spp. J Infect Chemother 6: 101-103, 2000. (Pubitemid 30480304)
19. Silvanose CD, Bailey TA, Di Somma A: Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole. Vet Rec 159: 282-284, 2006.